Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Journal of Translational Medicine|February 14, 2013
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanomaAntonio Daponte, Simona Signoriello, Luigi Maiorino, et al.European Journal of Cancer (Oxford, England : 1990)|October 24, 2006
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South ItalyMilena Casula, Maria Colombino, Maria P Satta, et al.International Journal of Molecular Sciences|July 20, 2021
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, et al.BMC Cancer|July 22, 2009
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian populationGrazia Palomba, Angela Loi, Antonella Uras, et al.Journal of Translational Medicine|June 3, 2014
Discrepant alterations in main candidate genes among multiple primary melanomasMaria Colombino, MariaCristina Sini, Amelia Lissia, et al.Journal of Clinical Medicine|October 5, 2019
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal MelanomasMaria Colombino, Panagiotis Paliogiannis, Antonio Cossu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanomaMaria Colombino, Mariaelena Capone, Amelia Lissia, et al.Oncotarget|December 7, 2017
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesisAntonio Cigliano, Maria G Pilo, Lei Li, et al.Pathologica|April 9, 2026
Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian projectBruna Cerbelli, Stefano Marletta, Michelina Amato, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup StudyMilena Casula, Maria Colombino, Maria P Satta, et al.Pageof 16